Acumen Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$2.40

+0.15 (+6.67%)

As of Feb 8, 2:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +825.8% upside

Low Target $18.81

Average Target $22.22

High Target $35.10

Current Price $2.40

Current
$2.40

Target
$22.22

$18.81 $22.22 avg $35.10

Scenario Analysis

Bear Case

$18.81

683.8%

Low target

Base Case

$22.22

+825.8%

Avg target

Bull Case

$35.10

+1,362.5%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$29.63

-91.9% from high

52-Week Low

$11.07

+-78.3% from low

Target vs 52W High

$22.22

-25.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%